Combination of Mesenchymal Stem Cells & Platelet-Rich Plasma for Knee Osteoarthritis
Combination of mesenchymal stem cells (MSCs) and platelet-rich plasma (PRP) in the treatment of knee osteoarthritis: a meta-analysis of randomised controlled trialsBMJ Open. 2022 Nov 16;12(11):e061008
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Six controlled clinical trials containing a total of 493 patients with knee osteoarthritis were included in this systematic review and meta-analysis comparing the combination of mesenchymal stem cells and platelet-rich plasma (n=204) with control (n=289; mesenchymal stem cells, platelet-rich plasma, or hyaluronic acid alone). Pooled outcomes of interest included pain on a Visual Analog Scale (VAS)...
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.Continue